Search in:

Advanced search

Clinical Ophthalmology Volume 9, 2015 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion

Yuka ItoDepartment of Ophthalmology, Shiga University of Medical Science, Otsu, Shiga, Japan

Yoshitsugu SaishinDepartment of Ophthalmology, Shiga University of Medical Science, Otsu, Shiga, JapanCorrespondence[email protected]

Osamu SawadaDepartment of Ophthalmology, Shiga University of Medical Science, Otsu, Shiga, Japan

Masashi KakinokiDepartment of Ophthalmology, Shiga University of Medical Science, Otsu, Shiga, Japan

Taichiro MiyakeDepartment of Ophthalmology, Shiga University of Medical Science, Otsu, Shiga, Japan

Tomoko SawadaDepartment of Ophthalmology, Shiga University of Medical Science, Otsu, Shiga, Japan

Hajime KawamuraDepartment of Ophthalmology, Shiga University of Medical Science, Otsu, Shiga, Japan

Masahito OhjiDepartment of Ophthalmology, Shiga University of Medical Science, Otsu, Shiga, Japan

show all

Pages 175-180 | Published online: 23 Jan 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

CakirMDoganMBayraktarZEfficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulationRetina200828346547218327140
PubMed Web of Science ®Google Scholar
RehakJRehakMBranch retinal vein occlusion: Pathogenesis, visual prognosis, and treatment modalitiesCurr Eye Res200833211113118293182
PubMed Web of Science ®Google Scholar
No authors listedArgon laser photocoagulation for macular edema in branch vein occlusion. The branch vein occlusion study groupAm J Ophthalmol19849832712826383055
PubMed Web of Science ®Google Scholar
Battaglia ParodiMSavianoSRavalicoGGrid laser treatment in macular branch retinal vein occlusionGraefes Arch Clin Exp Ophthalmol1999237121024102710654172
PubMed Web of Science ®Google Scholar
Battaglia ParodiMSavianoSBergaminiLRavalicoGGrid laser treatment of macular edema in macular branch retinal vein occlusionDoc Ophthalmol1999973–442743110896360
PubMed Web of Science ®Google Scholar
CekicOChangSTsengJJIntravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusionRetina200525785185516205563
PubMed Web of Science ®Google Scholar
HigashiyamaTSawadaOKakinokiMSawadaTKawamuraHOhjiMProspective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusionActa Ophthalmol201391431832422132711
PubMed Web of Science ®Google Scholar
RabenaMDPieramiciDJCastellarinAANasirMAAveryRLIntravitreal bevacizumab (avastin) in the treatment of macular edema secondary to branch retinal vein occlusionRetina200727441942517420692
PubMed Web of Science ®Google Scholar
GunduzKBakriSJIntravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusionEye (Lond)20082291168117118344969
PubMed Web of Science ®Google Scholar
MoradianSFaghihiHSadeghiBIntravitreal bevacizumab vs Sham treatment in acute branch retinal vein occlusion with macular edema: Results at 3 months (report 1)Graefes Arch Clin Exp Ophthalmol2011249219320021337043
PubMed Web of Science ®Google Scholar
YunokiTMiyakoshiANakamuraTFujitaKFuchizawaCHayashiATreatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumabJpn J Ophthalmol201256215916422246387
PubMed Web of Science ®Google Scholar
JaissleGBLeitritzMGeliskenFZiemssenFBartz-SchmidtKUSzurmanPOne-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusionGraefes Arch Clin Exp Ophthalmol20092471273318696094
PubMed Web of Science ®Google Scholar
KondoMKondoNItoYIntravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: Results after 12 months and multiple regression analysisRetina20092991242124819672216
PubMed Web of Science ®Google Scholar
ByunYJRohMILeeSCKohHJIntravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusionGraefes Arch Clin Exp Ophthalmol2010248796397120182882
PubMed Web of Science ®Google Scholar
DemirMObaEGulkilikGOdabasiMOzdalEIntravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month resultsClin Ophthalmol2011574574921750607
PubMedGoogle Scholar
KrohneTUEterNHolzFGMeyerCHIntraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humansAm J Ophthalmol2008146450851218635152
PubMed Web of Science ®Google Scholar
MiyakeTSawadaOKakinokiMPharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyesInvest Ophthalmol Vis Sci20105131606160819875666
PubMed Web of Science ®Google Scholar
BakriSJSnyderMRReidJMPulidoJSSinghRJPharmacokinetics of intravitreal bevacizumab (avastin)Ophthalmology2007114585585917467524
PubMed Web of Science ®Google Scholar
HeierJSBrownDMChongVIntravitreal afibercept (vegf trap-eye) in wet age-related macular degenerationOphthalmology201211922537254823084240
PubMed Web of Science ®Google Scholar
CostagliolaCAgnifliLArcidiaconoBSystemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degenerationExpert Opin Biol Ther201212101299131322866908
PubMed Web of Science ®Google Scholar
SemeraroFMorescalchiFDuseSGambicortiERomanoMRCostagliolaCSystemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overviewExpert Opin Drug Saf201413678580224809388
PubMed Web of Science ®Google Scholar
SchmidMKBachmannLMFäsLKesselsAGJobOMThielMAEfficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysisBr J Ophthalmol Epub2014611
Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date